000 01386 a2200361 4500
005 20250518065723.0
264 0 _c20200224
008 202002s 0 0 eng d
022 _a1469-493X
024 7 _a10.1002/14651858.CD003871.pub3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGeorge, Susannah Mc
245 0 0 _aInterventions to reduce Staphylococcus aureus in the management of eczema.
_h[electronic resource]
260 _bThe Cochrane database of systematic reviews
_c10 2019
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
650 0 4 _aAnti-Bacterial Agents
_xadverse effects
650 0 4 _aDermatologic Agents
_xtherapeutic use
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aEczema
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aStaphylococcal Infections
_xdrug therapy
650 0 4 _aStaphylococcus aureus
700 1 _aKaranovic, Sanja
700 1 _aHarrison, David A
700 1 _aRani, Anjna
700 1 _aBirnie, Andrew J
700 1 _aBath-Hextall, Fiona J
700 1 _aRavenscroft, Jane C
700 1 _aWilliams, Hywel C
773 0 _tThe Cochrane database of systematic reviews
_gvol. 2019
_gno. 10
856 4 0 _uhttps://doi.org/10.1002/14651858.CD003871.pub3
_zAvailable from publisher's website
999 _c30271479
_d30271479